Phase II trial of five fractions of radiotherapy followed by four cycles of FOLFOX chemotherapy as preoperative therapy for rectal adenocarcinoma: Report of an interim response analysis.
R. J. Myerson
No relevant relationships to disclose
S. R. Hunt
No relevant relationships to disclose
B. R. Tan
No relevant relationships to disclose
P. Parikh
No relevant relationships to disclose
A. C. Lockhart
No relevant relationships to disclose
J. Picus
No relevant relationships to disclose
S. Sorscher
No relevant relationships to disclose
R. Suresh
No relevant relationships to disclose
A. Wang-Gillam
No relevant relationships to disclose
J. W. Fleshman
No relevant relationships to disclose
I. J. Kodner
No relevant relationships to disclose